WINTON GROUP Ltd Buys 363,928 Shares of Avantor, Inc. $AVTR

WINTON GROUP Ltd raised its stake in Avantor, Inc. (NYSE:AVTR) by 797.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 409,558 shares of the company’s stock after acquiring an additional 363,928 shares during the period. WINTON GROUP Ltd owned approximately 0.06% of Avantor worth $5,111,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Royal Bank of Canada raised its stake in Avantor by 104.3% in the first quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock valued at $3,302,000 after purchasing an additional 104,022 shares in the last quarter. Empowered Funds LLC lifted its position in Avantor by 40.3% during the first quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock worth $286,000 after purchasing an additional 5,075 shares during the period. Envestnet Asset Management Inc. grew its stake in Avantor by 11.0% during the second quarter. Envestnet Asset Management Inc. now owns 757,056 shares of the company’s stock worth $10,190,000 after buying an additional 74,731 shares in the last quarter. Atria Investments Inc increased its holdings in Avantor by 101.3% in the 2nd quarter. Atria Investments Inc now owns 43,603 shares of the company’s stock valued at $587,000 after buying an additional 21,938 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in Avantor by 5.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,038,544 shares of the company’s stock valued at $67,819,000 after buying an additional 258,268 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Gregory T. Lucier bought 50,000 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The shares were acquired at an average price of $9.16 per share, for a total transaction of $458,000.00. Following the completion of the acquisition, the director directly owned 50,000 shares in the company, valued at approximately $458,000. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Gregory L. Summe bought 100,000 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The stock was purchased at an average price of $9.40 per share, for a total transaction of $940,000.00. Following the acquisition, the director owned 400,000 shares of the company’s stock, valued at $3,760,000. This trade represents a 33.33% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 1.20% of the company’s stock.

Avantor Price Performance

Avantor stock opened at $8.14 on Tuesday. The stock’s 50 day moving average is $10.64 and its 200 day moving average is $11.81. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.18. The firm has a market cap of $5.55 billion, a P/E ratio of -10.43, a P/E/G ratio of 3.21 and a beta of 0.97. Avantor, Inc. has a one year low of $7.82 and a one year high of $18.02.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The business had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm posted $0.27 EPS. The company’s revenue for the quarter was down 1.4% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, research analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently commented on AVTR shares. Robert W. Baird set a $11.00 target price on shares of Avantor in a research report on Thursday, February 12th. Zacks Research cut shares of Avantor from a “hold” rating to a “strong sell” rating in a research note on Friday, February 13th. Barclays restated an “underweight” rating and set a $8.50 price objective on shares of Avantor in a research report on Friday. Jefferies Financial Group restated an “underperform” rating and set a $8.00 target price on shares of Avantor in a research note on Thursday, February 12th. Finally, Wells Fargo & Company reduced their target price on Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Three investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $11.80.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.